NCT05200884

Brief Summary

Aims: Comparison of injection pain with lidocaine and articaine in children with MIH . Comparison of the efficacy of lidocaine and articaine during treatment of MIH molars. Design: A randomized, controlled, crossover, double-blind clinical study including twenty cooperative children, aged 6-12years old

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Jan 2022

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 21, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

January 22, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2022

Completed
Last Updated

July 15, 2022

Status Verified

January 1, 2022

Enrollment Period

2 months

First QC Date

December 15, 2021

Last Update Submit

July 14, 2022

Conditions

Keywords

the local anesthesiaLidocaine 2%Articaine 4%childrenMIH molars.

Outcome Measures

Primary Outcomes (4)

  • dental pain

    evaluated by outcome assessor using the Faces, Legs, Activity, Cry, Consolability Behavioral Pain Rating Scale ( FLACC scale ) ( a behavioral pain assessment scale which has five criteria face, legs, activity, cry, consolability ,which are each assigned a score of 0, 1 or 2.Total score of scale is summed in range 0 to 10, where: 0=relaxed and comfortable; 1-3=mild discomfort; 4-6=moderate pain; 7-10=severe pain)..

    during the injection of local anesthesia

  • dental pain

    self assessment pain by the children using Wong-Baker faces pain rating scale (a scale shows a series of faces ranging from a happy face at 0, or "no hurt", to a crying face at 10,which represents "hurts like the worst pain imaginable" )

    Immediately after the injection of local anesthesia

  • dental pain

    evaluated by outcome assessor using the Faces, Legs, Activity, Cry, Consolability Behavioral Pain Rating Scale ( FLACC scale ) ( a behavioral pain assessment scale which has five criteria face, legs, activity, cry, consolability ,which are each assigned a score of 0, 1 or 2.Total score of scale is summed in range 0 to 10, where: 0=relaxed and comfortable; 1-3=mild discomfort; 4-6=moderate pain; 7-10=severe pain)..

    during treatment

  • dental pain

    self assessment pain by the children using Wong-Baker faces pain rating scale (a scale shows a series of faces ranging from a happy face at 0, or "no hurt", to a crying face at 10,which represents "hurts like the worst pain imaginable" )

    Immediately after the treatment

Study Arms (2)

: A (Lidocaine 2%)

ACTIVE COMPARATOR

20 children will be injected with 1 ml of lidocaine 2% with epinephrine. each one received lidocaine2% at his\\her first or second visit. Half of the total number of injections for 20 children i.e. 20 injections will be distributed randomly to the two drugs using the randomization table

Drug: Lidocaine 2%

B (Articaine 4%)

EXPERIMENTAL

20 children will be injected with 1 ml of Articaine 4% with epinephrine. each one received articaine 4% at his\\her first or second visit. Half of the total number of injections for 20 children i.e.20 injections will be distributed randomly to the two drugs using the randomization table

Drug: Articaine 4%

Interventions

The child will be injected with lidocaine 2% and After 10 minutes the treatment will be completed , Pain during injection and treatment will be assessed using the FLACC scale and pain after injection and treatment will be evaluated using the Wong-Baker FACES pain rating scale

Also known as: A
: A (Lidocaine 2%)

The child will be injected with 4% Articaine and After 10 minutes the treatment will be completed , Pain during injection and treatment will be assessed using the FLACC scale and face scale

Also known as: B
B (Articaine 4%)

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Absolute positive or positive behavior according to the Frankel Scale.
  • Healthy, both physically and mentally.
  • Do not take medications that interfere with the assessment of pain within 24 hours prior to treatment.
  • A child with a MIH-affected mandibular permanent first molar on the right and left sides .

You may not qualify if:

  • Teeth with non-response pulpitis Inflammation at the injection site.
  • Allergy to the substances used in anesthesia.
  • Presence of general or developmental medical conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tishreen University

Latakia, Syria

Location

Related Publications (1)

  • Haidar M, Raslan N. Comparative study of articaine 4% versus lidocaine 2% in the local anesthesia of permanent mandibular first molars affected by MIH: a randomized controlled trial. Eur Arch Paediatr Dent. 2023 Oct;24(5):621-630. doi: 10.1007/s40368-023-00827-w. Epub 2023 Aug 1.

MeSH Terms

Conditions

Molar Hypomineralization

Condition Hierarchy (Ancestors)

Dental Enamel HypomineralizationDevelopmental Defects of EnamelTooth AbnormalitiesStomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Nabih Raslan, Dr

    Tishreen University

    STUDY CHAIR
  • Mai Haidar, Dr

    Tishreen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The participant will be blinded, the drug administrator will be blinded too, and the investigator who will give the treatment and explain the pain scale to the participant and ask him\\her to point to the face that fits the degree of his pain that associated with the drug administration will also be blinded.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: A randomized, controlled, crossover, double-blind clinical study, Comparison of articaine 4% and lidocaine 2%
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2021

First Posted

January 21, 2022

Study Start

January 22, 2022

Primary Completion

March 25, 2022

Study Completion

June 10, 2022

Last Updated

July 15, 2022

Record last verified: 2022-01

Locations